Pneumococcal disease is a deadly infectious disease that kills 1.6 million people each year, including 800,000 children under age five. Global awareness of this deadly disease, however, remains low. Sabin convenes the world’s leading experts in epidemiology and other key public health professionals at regional and country-level symposia, including the Regional Pneumococcal Symposium. Developed in collaboration with the World Health Organization (WHO), the Pan American Health Organization (PAHO), the U.S.
In recent years mass vaccination campaigns in Latin America have resulted in significant progress in improving health throughout the region, including the eradication and elimination of polio, measles and rubella in the Americas. Many countries are looking to expand vaccination coverage and introduce new vaccines, such as those against hepatitis B, Haemophilus Influenzae type b (Hib), rotavirus, human papilloma virus (HPV) and pneumococcal disease. But as more vaccines become available, it becomes increasingly important to understand the current guidelines and recommendations re
The Advisory Committee on Immunization Practices (ACIP) is a group of 15 immunization experts who assist in determining vaccination recommendations for the United States. Based on their own knowledge, as well as research results, committee recommendations, cost-effective analyses and a range of other information, the ACIP recommends which vaccines should be used, which populations should be vaccinated, and how frequently the vaccinations should be administered
Sabin Vaccine Institute convoque des représentants des gouvernements pour
Sabin Vaccine Institute convenes government officials to discuss progress on sustainable imm
Sabin is working in Latin America to bring together experts to discuss some of the key questions of dengue burden and vaccine introduction. Sabin is coordinating a two day regional workshop to convene key health and government officials from the region, as well as officials from the Pan American Health Organization (PAHO) and representatives from multilateral agencies and other stake holders, to discuss how to measure efficacy of a future dengue vaccine and to develop a proposed set of guidelines on methodologies to be used.